Nachrichten zur AstraZeneca PLC Aktie

AstraZeneca erwägt Abspaltung des China-Geschäfts

Pharma - Der britisch-schwedische Arzneimittelhersteller AstraZeneca erwägt einem Zeitungsbericht zufolge eine Abspaltung seines China-Geschäfts....…

AstraZeneca Reportedly Weighs Spin-off for CN Biz with Potential HK IPO

Pharmaceutical firm AstraZeneca is drafting a plan to spin off its China business and may pursue a separate listing for…

AstraZeneca Drafts Plan to Spin Off China Business, FT Says

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca planning China business spin off -FT

...(Reuters) - Drugmaker AstraZeneca is drafting a plan to spin off......…

Berufungsverfahren gegen Impfstoffhersteller wegen Schadenersatz

BAMBERG (dpa-AFX) - Ein halbes Jahr nach der Abweisung einer Schadenersatzklage gegen den Impfstoffhersteller Astrazeneca …

Astrazeneca (AZN) Gains But Lags Market: What You Should Know

Astrazeneca (AZN) closed the most recent trading day at $74.13, moving +0.38% from the previous trading session....…

AstraZeneca (AZN) Breast Cancer Combo Drug Gets Priority Review

The FDA grants priority review status to AstraZenecas (AZN) capivasertib/Faslodex combination for the treatment of adult patients with HR-positive, HER2-negative…

AstraZeneca to decarbonize U.S. footprint by turning cow manure into renewable natural gas

In a first for the pharma sector, AstraZeneca will tap renewable natural gas for its U.S. manufacturing sites by the…

AstraZeneca Partners Vanguard Renewables To Use Renewable Natural Gas In The U.S. By End Of 2026

LONDON (dpa-AFX) - In a first-of-its-kind collaboration, British drug major AstraZeneca plc (AZN, AZN.L) is partnering with Vanguard Renewables to…

Vanguard Renewables Announces Innovative Partnership With AstraZeneca to Decarbonize United States Medicines Manufacturing

Agreement will deliver renewable natural gas to U.S. research and manufacturing sites, starting in Newark, Delaware, and accelerate progress on…

AstraZeneca turns to cows to cut U.S. carbon footprint

...By Natalie Grover LONDON (Reuters) - Drugmaker AstraZeneca......…

AstraZeneca wins approval in China for Soliris in myasthenia gravis

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

Astrazeneca erhält in China Zulassung für Soliris

Von Joe Hoppe LONDON (Dow Jones)--Astrazeneca hat in China die Zulassung für das Medikament Soliris (Eculizumab) für Erwachsene zur…

BRIEF-Soliris Approved In China For The Treatment Of Adults With Refractory Generalised Myasthenia Gravis, 13 June 2023

...June 13 (Reuters) - AstraZeneca PLC: * SOLIRIS APPROVED IN CHINA......…

Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know

Astrazeneca (AZN) closed the most recent trading day at $73.85, moving -0.28% from the previous trading session....…

AstraZeneca (AZN) & Quell to Co-Develop Autoimmune Cell Therapies

AstraZeneca (AZN) enters into a collaboration agreement with Quell Therapeutics to co-develop novel cell therapy options in major autoimmune indications…

AstraZeneca breast cancer drug capivasertib gets priority review in US

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca in deal with start-up to fight diabetes

The FTSE 100 firm will team up with London-based Quell Therapeutics to collaborate on research and the licensing of any…

AstraZeneca in pact with Quell Therapeutics for Treg cell therapies

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 6-K ASTRAZENECA PLC For: Jun 09

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

TOP NEWS: AstraZeneca hails deal with Quell; positive danicopan data

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca places $85 million bet on autoimmune cell therapy with ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca signs $2 bln agreement with Quell to develop cell therapies

...June 9 (Reuters) - AstraZeneca said on Friday it had signed......…

AstraZeneca signs $2 billion agreement with Quell to develop cell therapies

...(Reuters) - AstraZeneca said on Friday it had signed an agreement......…

AstraZeneca places US$85mln bet on autoimmune cell therapy with ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

BRIEF-Astrazeneca Says Results From Alpha Phase III Trial Demonstrated Statistically Increase In Haemoglobin

...June 9 (Reuters) - AstraZeneca PLC: * ASTRAZENECA - DANICOPAN AS ADD......…

FDA-Ausschuss empfiehlt Nirsevimab zur RSV-Prävention bei Kleinkindern

Von Joe Hoppe LONDON (Dow Jones)--Der von den Pharmakonzernen Astrazeneca und Sanofi gemeinsam entwickelte Antikörper Nirsevimab ist von einem…

AstraZeneca: FDA Committee Recommends Nirsevimab For RSV Lower Respiratory Tract Disease In Infants

LONDON (dpa-AFX) - British drug major AstraZeneca Plc (AZN, AZN.L) announced Friday that the US Food and Drug Administration Antimicrobial…

Astrazeneca schließt mit Quell Vereinbarung über Treg-Zell-Therapien

Von Anthony O. Goriainoff LONDON (Dow Jones)--Astrazeneca hat mit Quell Therapeutics eine Zusammenarbeit bei der Entwicklung, Herstellung und Vermarktung…

Syncona: Quell Signs Cell Therapy Deal With AstraZeneca Focused On Autoimmune Diseases

LONDON (dpa-AFX) - Healthcare investment company Syncona Limited (SYNC.L) announced Friday that Quell Therapeutics, a developer of engineered T-regulatory (Treg)…

AstraZeneca Says Nirsevimab Recommended for RSV Prevention in Infants by FDA Body

AstraZeneca Says Nirsevimab Recommended for RSV Prevention in Infants by FDA Body...…

BUSINESS LIVE: North Sea windfall tax to be reformed

Among the companies with reports and trading updates today are Mothercare, CMC Markets, Croda International, AstraZeneca, S4 Capital and MP…

AstraZeneca Reaches Agreement With Quell Therapeutics for Treg Cell Therapies

AstraZeneca Reaches Agreement With Quell Therapeutics for Treg Cell Therapies...…

AstraZeneca hails RSV drug nirsevimab recommendation by FDA committee

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

nirsevimab recommended for infant RSV protection

9 June 2023 Nirsevimab unanimously recommended by FDA Advisory Committee for the prevention of RSV lower respiratory tract disease in infants If approved,…

AstraZeneca agreement with Quell Therapeutics

09 June 2023 AstraZeneca announces agreement with Quell Therapeutics to develop, manufacture and commercialise engineered T-regulatory cell therapies for autoimmune diseases Collaboration focused on…

AstraZeneca, Sanofi win FDA advisory committee backing for RSV therapy nirsevimab

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Infant RSV Drug From Sanofi, AstraZeneca Wins Backing of Key ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

FDA advisers vote in favor of AstraZeneca, Sanofi antibody for infant RSV protection

Advisers to the U.S. Food and Drug Administration voted unanimously Thursday to recommend a monoclonal antibody developed by Sanofi SNY…

FDA advisors recommend AstraZeneca antibody to protect babies from RSV

If the Food and Drug Administration approves nirsevimab, it will be the first medical intervention available in the U.S. that…

AstraZeneca: Broker upbeat after American cancer conference data ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca and Daiichi Sankyo report progress in cancer drug trials

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca (AZN) Anticoagulant Drug Study Meets Efficacy Goal

At the interim analysis, AstraZenecas (AZN) drug Andexxa showed superior hemostatic efficacy or in other words improved control of bleeding…

Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....…

AstraZeneca Reports Positive Results From Interim Analysis Of DESTINY-PanTumor02 Phase II Trial

LONDON (dpa-AFX) - AstraZeneca PLC (AZN.L, AZN) and Daiichi Sankyos Enhertu showed an objective response rate of 37.1% in the…

AstraZeneca Neutral

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Astrazeneca auf "Neutral" mit einem Kursziel von 12500…

AstraZeneca Cancer Drug Enhertu Shows Clinically Meaningful, Durable Response in Trial

AstraZeneca Cancer Drug Enhertu Shows Clinically Meaningful, Durable Response in Trial...…

AstraZeneca stops Andexxa trial early, Tagrisso reduces death risk

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

AstraZeneca Says Andexxa Phase IV Trial Stopped Early On Achieving Efficacy Goal

LONDON (dpa-AFX) - AstraZeneca PLC (AZN.L) on Monday said the Phase 4 study of Andexxa in patients on oral FXa-inhibitor…

Lung cancer pill cuts risk of death by half, study finds

The drug, developed by AstraZeneca, if taken daily after surgery, dramatically reduces risk of death, study shows....…